Detection of acquired TERT amplification in addition to predisposing p53 and Rb pathways alterations in EGFR-mutant lung adenocarcinomas transformed into small-cell lung cancers.

MLA

Mc Leer, Anne, et al. “Detection of Acquired TERT Amplification in Addition to Predisposing P53 and Rb Pathways Alterations in EGFR-Mutant Lung Adenocarcinomas Transformed into Small-Cell Lung Cancers.” Lung Cancer (Amsterdam, Netherlands), vol. 167, May 2022, pp. 98–106. EBSCOhost, https://doi.org/10.1016/j.lungcan.2022.01.008.

APA

Mc Leer, A., Foll, M., Brevet, M., Antoine, M., Novello, S., Mondet, J., Cadranel, J., Girard, N., Giaj Levra, M., Demontrond, P., Audigier-Valette, C., Letouzé, E., Lantuéjoul, S., Fernandez-Cuesta, L., & Moro-Sibilot, D. (2022). Detection of acquired TERT amplification in addition to predisposing p53 and Rb pathways alterations in EGFR-mutant lung adenocarcinomas transformed into small-cell lung cancers. Lung Cancer (Amsterdam, Netherlands), 167, 98–106. https://doi.org/10.1016/j.lungcan.2022.01.008

Chicago

Mc Leer, Anne, Matthieu Foll, Marie Brevet, Martine Antoine, Silvia Novello, Julie Mondet, Jacques Cadranel, et al. 2022. “Detection of Acquired TERT Amplification in Addition to Predisposing P53 and Rb Pathways Alterations in EGFR-Mutant Lung Adenocarcinomas Transformed into Small-Cell Lung Cancers.” Lung Cancer (Amsterdam, Netherlands) 167 (May): 98–106. doi:10.1016/j.lungcan.2022.01.008.